183 related articles for article (PubMed ID: 7930220)
21. Expiratory increase in the LV outflow obstruction in IHSS.
Reddy CV; Gould L; Singh BK; Zen B
Cathet Cardiovasc Diagn; 1980; 6(3):349-50. PubMed ID: 7192605
[No Abstract] [Full Text] [Related]
22. Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening.
Migliore F; Zorzi A; Michieli P; Perazzolo Marra M; Siciliano M; Rigato I; Bauce B; Basso C; Toazza D; Schiavon M; Iliceto S; Thiene G; Corrado D
Circulation; 2012 Jan; 125(3):529-38. PubMed ID: 22179535
[TBL] [Abstract][Full Text] [Related]
23. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities.
Pelliccia A; Zipes DP; Maron BJ
J Am Coll Cardiol; 2008 Dec; 52(24):1990-6. PubMed ID: 19055990
[TBL] [Abstract][Full Text] [Related]
24. Mitral valve prolapse and hypertrophic cardiomyopathy in a pup.
Swindle MM; Huber AC; Kan JS; Starr FL; Samphilipo MA
J Am Vet Med Assoc; 1984 Jun; 184(12):1515-7. PubMed ID: 6539766
[No Abstract] [Full Text] [Related]
25. Mitral valve prolapse and idiopathic hypertrophic subaortic stenosis: two sources of chest pain in young adults.
Oertel T; Love M
J Emerg Nurs; 1983; 9(1):21-6. PubMed ID: 6338276
[No Abstract] [Full Text] [Related]
26. [Clinical aspects of myocardial diseases].
Baedeker W
Dtsch Med J; 1969 Jul; 20(13):417-20. PubMed ID: 5816564
[No Abstract] [Full Text] [Related]
27. Recommendations for participation in competitive sport in athletes with hypertrophic cardiomyopathy: opening the sacks of Aeolus.
Pagourelias ED; Kouidi E; Vassilikos VP
Eur Heart J; 2019 Sep; 40(36):3064. PubMed ID: 31292626
[No Abstract] [Full Text] [Related]
28. Arrhythmic Mitral Valve Prolapse: Implications for Family Screening and Sports Participation Eligibility.
Papatheodorou E; Anastasakis A
J Am Coll Cardiol; 2020 Dec; 76(22):2691. PubMed ID: 33243392
[No Abstract] [Full Text] [Related]
29. Primary versus secondary mitral valve prolapse: clinical features and implications.
Levine HJ; Isner JM; Salem DN
Clin Cardiol; 1982 Jun; 5(6):371-5. PubMed ID: 7049478
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular evaluation of the young athlete.
Strong WB; Steed D
Pediatr Clin North Am; 1982 Dec; 29(6):1325-39. PubMed ID: 7177724
[No Abstract] [Full Text] [Related]
31. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. January 6-7, 1994.
Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S223-83. PubMed ID: 7799776
[No Abstract] [Full Text] [Related]
32. 26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. January 6-7, 1994.
J Am Coll Cardiol; 1994 Oct; 24(4):845-99. PubMed ID: 7798484
[No Abstract] [Full Text] [Related]
33. Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease.
Naccarelli GV; Prystowsky EN; Jackman WM; Heger JJ; Rahilly GT; Zipes DP
Am J Cardiol; 1982 Jul; 50(1):165-71. PubMed ID: 7201234
[No Abstract] [Full Text] [Related]
34. Legal considerations that affect medical eligibility for competitive athletes with cardiovascular abnormalities and acceptance of Bethesda Conference recommendations.
Mitten MJ; Maron BJ
Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S238-41. PubMed ID: 7934745
[No Abstract] [Full Text] [Related]
35. Legal considerations that affect medical eligibility for competitive athletes with cardiovascular abnormalities and acceptance of Bethesda Conference recommendations.
Mitten MJ; Maron BJ
J Am Coll Cardiol; 1994 Oct; 24(4):861-3. PubMed ID: 7930216
[No Abstract] [Full Text] [Related]
36. [Abnormalities in electrocardiogram of patients with rheumatoid arthritis].
Hashimoto N; Sano H
Nihon Rinsho; 2005 Jan; 63 Suppl 1():390-1. PubMed ID: 15799385
[No Abstract] [Full Text] [Related]
37. [The value of M-mode echocardiography in children].
Schmaltz AA
Fortschr Med; 1980 Jun; 98(22):862-4. PubMed ID: 7190955
[TBL] [Abstract][Full Text] [Related]
38. Pericarditis, myocarditis, and other cardiomyopathies.
Shammas NW; Padaria RF; Coyne EP
Prim Care; 2013 Mar; 40(1):213-36. PubMed ID: 23402470
[TBL] [Abstract][Full Text] [Related]
39. Coexistence of mitral valve prolapse in a consecutive group of 528 patients with hypertrophic cardiomyopathy assessed with echocardiography.
Petrone RK; Klues HG; Panza JA; Peterson EE; Maron BJ
J Am Coll Cardiol; 1992 Jul; 20(1):55-61. PubMed ID: 1607539
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular magnetic resonance assessment of ischemic and nonischemic cardiomyopathies.
Raney AR; Bello D
Heart Fail Clin; 2006 Apr; 2(2):145-61. PubMed ID: 17386886
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
